PATENT CLAIM ANALYSIS

Application Number: 15778213
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "492000"]

Abstract:
Disclosed herein, inter alia, are platinum-based compounds useful for treating cancer.

Claim (Index 17):
The method of  claim 16 , wherein said cancer is glioblastoma, kidney cancer, neuroblastoma, rhabdomyosarcoma, osteosarcoma, colorectal cancer, liver cancer, renal cancer, renal cell carcinoma, bladder cancer, lung cancer, non-small cell lung cancer, ovarian cancer, uterine cancer, cervical cancer, testicular cancer, anal cancer, bile duct cancer, biliary tract cancer, gastrointestinal carcinoid tumors, esophageal cancer, gall bladder cancer, appendix cancer, small intestine cancer, stomach (gastric) cancer, urinary bladder cancer, genitourinary tract cancer, endometrial cancer, head and neck cancer, nasopharyngeal cancer, head and neck squamous cell carcinoma, mesothelioma, lymphoma, leukemia, breast cancer, or prostate cancer.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 93.0
- Lexical Diversity: 1.07692
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15760959', '14175295', '15757238', '15614278', '14849428']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8153126957247899
- 35 USC 102 Novelty (BERT): 0.5593429320050354
- Combined Prediction Score: 0.7897157193528145
- Mean Citation Score: 462.703324
- Max Citation Score: 476.58414000000016
- Similarity Product: 275.1861444212724

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test